Liver disease in ulcerative colitis.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001650:Bile Duct Neoplasms / Q000150:complications; D001652:Bile Ducts; D001706:Biopsy; D002761:Cholangitis / Q000150:complications; D002779:Cholestasis / Q000209:etiology; D003082:Colectomy / Q000401:mortality; D003093:Colitis, Ulcerative / Q000150:complications* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D005234:Fatty Liver / Q000150:complications; D005500:Follow-Up Studies; D006505:Hepatitis / Q000150:complications; D006801:Humans; D007249:Inflammation; D008099:Liver / Q000473:pathology; D008103:Liver Cirrhosis / Q000150:complications; D008105:Liver Cirrhosis, Biliary / Q000150:complications; D008107:Liver Diseases / Q000150:complications*; D008111:Liver Function Tests; D011168:Portal System / Q000473:pathology; D011239:Prednisolone; D018805:Sepsis / Q000150:complications; D013752:Tetracycline / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D011239:Prednisolone; D013752:Tetracycline